Spiriva® Assessment of FEV1 (SAFE)

Clinical trial NCT00277264 · COMPLETED

Trial details

NCT number: NCT00277264
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2002-01-01
Primary completion: 2004-05-01
Enrollment: 914

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.